Roche (OTCMKTS:RHHBY) Share Price Crosses Below 50-Day Moving Average – Time to Sell?

Roche Holding AG (OTCMKTS:RHHBY) shares crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $50.77 and traded as low as $48.83. Roche shares last traded at $49.00, with a volume of 1,914,382 shares traded.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on RHHBY shares. Morgan Stanley raised Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target for the company in a research report on Friday, April 24th. Argus raised Roche from a “hold” rating to a “buy” rating in a research report on Monday, April 6th. TD Cowen reissued a “hold” rating on shares of Roche in a research report on Tuesday, February 10th. Finally, Wolfe Research reissued an “outperform” rating on shares of Roche in a research report on Thursday, February 26th. Five research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $51.50.

Roche Trading Down 0.1%

The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.12 and a current ratio of 1.38. The company has a 50 day simple moving average of $50.77 and a two-hundred day simple moving average of $52.27.

Institutional Trading of Roche

Several large investors have recently added to or reduced their stakes in the company. Oakworth Capital Inc. grew its stake in Roche by 20.8% during the 4th quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock valued at $86,000 after purchasing an additional 285 shares during the last quarter. Enterprise Financial Services Corp grew its stake in Roche by 6.6% during the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock valued at $277,000 after purchasing an additional 345 shares during the last quarter. Archer Investment Corp grew its stake in Roche by 7.7% during the 1st quarter. Archer Investment Corp now owns 5,598 shares of the company’s stock valued at $278,000 after purchasing an additional 398 shares during the last quarter. Diversified Trust Co grew its stake in Roche by 0.8% during the 1st quarter. Diversified Trust Co now owns 59,375 shares of the company’s stock valued at $2,907,000 after purchasing an additional 448 shares during the last quarter. Finally, Fulton Bank N.A. grew its stake in Roche by 4.6% during the 4th quarter. Fulton Bank N.A. now owns 11,659 shares of the company’s stock valued at $604,000 after purchasing an additional 508 shares during the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.